Recruiting Sickle Cell Disease Studies in Philadelphia
About Sickle Cell Disease Clinical Trials in Philadelphia
Sickle cell disease is a group of inherited blood disorders where abnormal hemoglobin causes red blood cells to become rigid and sickle-shaped. It causes pain crises, organ damage, and shortened life expectancy. Treatment includes hydroxyurea, blood transfusions, and gene therapy.
There are currently 7 sickle cell disease clinical trials recruiting participants in Philadelphia, PA. These studies are seeking a combined 1,113 participants. Research is being sponsored by RTI International, Children's Hospital Medical Center, Cincinnati, Novartis Pharmaceuticals and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Sickle Cell Disease Clinical Trials in Philadelphia — FAQ
Are there sickle cell disease clinical trials in Philadelphia?
Yes, there are 7 sickle cell disease clinical trials currently recruiting in Philadelphia, PA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Philadelphia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.
Are clinical trials in Philadelphia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.
What sickle cell disease treatments are being tested?
The 7 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for sickle cell disease.
Data updated July 19, 2026 from ClinicalTrials.gov